Pancreatic Cancer

PANCREATIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Multidisciplinary Genetic Tumor Boards: Critical for Interpreting Tumor-Only Sequencing Results

One approach for improving recommendations based on tumor-only sequencing is use of a multidisciplinary genomic tumor board, in which researchers from a variety of backgrounds weigh in on the best way to interpret test results.
The Revival of a Forgotten Cancer Gene Therapy With Off-the-Shelf Potential

A universal cancer gene therapy from the early 2000s is headed into phase 2 trials, in light of renewed interest and outlier patients who are still alive at 10 years later.
Navigating Cancer Communication on Twitter

Twitter is increasingly being used by oncologists as a tool to communicate advancements in in the treatment of cancer. What could go wrong?
Wider Use of Basket Trials Could Hasten Development of Precision Therapies

Basket trials are those that test investigational therapies in patients who have different types of cancer but share a particular genomic aberration.
Unlocking the Potential of Biosimilars in Community Oncology

Full adoption of biosimilars will require proper provider and patient education, payer coverage navigation support, and streamlined workflows.

PANCREATIC CANCER NEWS

Some patients diagnosed with HP or AP have a significantly increased risk of developing pancreatic c

ASCO Guideline Update: Modified FOLFIRINOX Is Preferred as Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma

June 18, 2019

Pain management continues to be a challenge for patients with pancreatic cancer, though CPN may prov

Maintenance Olaparib May Delay Progression of BRCA-Related Pancreatic Cancer

June 3, 2019

Endoscope Detects Pancreatic Cancer

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma

May 30, 2019

Recent research shows that enoxaparin effectively prevents VTE complications in advanced pancreatic

FFPE Tissue Specimens Deemed Adequate for Molecular Studies: NCI-SEER

April 2, 2019

New, less aggressive guidelines have been developed for management of pancreatic cysts.

Predicting Benefit From Olaparib Maintenance in Metastatic Pancreatic Cancer: The POLO Trial

March 4, 2019

Next post in Pancreatic Cancer

Endoscope Detects Pancreatic Cancer

Cancer Consultation Low in Noncurable Pancreatic Adenocarcinoma